stoxline Quote Chart Rank Option Currency Glossary
  
Check-Cap Ltd. (CHEK)
3.11  0.36 (13.09%)    03-28 16:00
Open: 2.57
High: 3.45
Volume: 434,179
  
Pre. Close: 2.75
Low: 2.5101
Market Cap: 18(M)
Technical analysis
2024-03-28 4:50:25 PM
Short term     
Mid term     
Targets 6-month :  4.02 1-year :  4.7
Resists First :  3.45 Second :  4.02
Pivot price 2.12
Supports First :  2.41 Second :  1.77
MAs MA(5) :  2.46 MA(20) :  2.08
MA(100) :  2.45 MA(250) :  2.57
MACD MACD :  0.1 Signal :  0
%K %D K(14,3) :  77.6 D(3) :  71.9
RSI RSI(14): 79.9
52-week High :  4.62 Low :  1.25
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ CHEK ] has closed above the upper band by 20.3%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 161.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.45 - 3.47 3.47 - 3.48
Low: 2.48 - 2.5 2.5 - 2.51
Close: 3.09 - 3.11 3.11 - 3.13
Company Description

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Headline News

Thu, 28 Mar 2024
Check-Cap Ltd. Calls Shareholders to Vote on Executive Compensation and Board Changes - TipRanks.com - TipRanks

Thu, 28 Mar 2024
Check Cap Ltd (CHEK) Down 10.18% in Premarket Trading - InvestorsObserver

Thu, 28 Mar 2024
Check-Cap (CHEK) Scheduled to Post Quarterly Earnings on Friday - Defense World

Tue, 26 Mar 2024
AI-Powered Real Estate Marketplace Nobul AI To Acquire Medical-Diagnostics Company Check-Cap - MSN

Tue, 26 Mar 2024
Should You Buy Check Cap Ltd (CHEK) Stock Tuesday Morning? - InvestorsObserver

Tue, 26 Mar 2024
Check-Cap jumps on Nobul AI business combination (NASDAQ:CHEK) - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Diagnostics & Research
Shares Out 6 (M)
Shares Float 5 (M)
Held by Insiders 12.1 (%)
Held by Institutions 1.1 (%)
Shares Short 14 (K)
Shares Short P.Month 62 (K)
Stock Financials
EPS -3.01
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 4.67
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -28.7 %
Return on Equity (ttm) -48.8 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -3.03
Qtrly Earnings Growth 0 %
Operating Cash Flow -18 (M)
Levered Free Cash Flow -13 (M)
Stock Valuations
PE Ratio -1.04
PEG Ratio 0
Price to Book value 0.66
Price to Sales 0
Price to Cash Flow -1.04
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android